Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Molecular & General Genetics : MGG|December 31, 1998
Instability at the k2 Mdh1-n y20 chromosomal region in soybeanX F Chen, R G PalmerZhong Xi Yi Jie He Za Zhi = Chinese Journal of Modern Developments in Traditional Medicine|July 1, 1989
[NK cell activity in patients with kidney insufficiency]X F Chen, P X WangZhonghua Yi Shi Za Zhi (Beijing, China : 1980)|October 15, 2018
[The study of crude drugs producing regions, genuine producing regions and its distribution in Bencao Tujing]X F Chen, H S PengZhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|May 23, 2023
[Relationship between smoking and the risk of morbidity of chronic obstructive pulmonary diseases among residents aged 30 years and above in Sichuan Province: a prospective study]G J Wei, X F Chen, X F Chen, et al.Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|January 1, 1993
[3,4-Diaminopyridine-evoked norepinephrine release and B-50 (GAP-43) phosphorylation]H Y Huang, T Tang, X F ChenZhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 5, 2016
[Prevalence and risk factors of hypertension among residents of 30 years or above years old in Pengzhou city of Sichuan province]G J Luo, M Luo, X F Chen, et al.Plant Disease|February 1, 2019
First Report of Dickeya solani Causing Soft Rot in Imported Bulbs of Hyacinthus orientalis in ChinaX F Chen, H L Zhang, J ChenEuropean Review for Medical and Pharmacological Sciences|July 13, 2019
MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2H-B Gao, F-Z Gao, X-F ChenZhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 24, 2017
[Clinical effect of 156-week telbivudine sequential therapy in HBeAg-positive chronic hepatitis B patients with suboptimal response to pegylated interferon-α-2a therapy]X D Luo, X P Chen, X F ChenZhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 12, 2018
[Optimal treatment regimen for patients with HBeAg-positive chronic hepatitis B after suboptimal response to 24 weeks of Peg-IFN α-2a]X D Luo, X P Chen, X F ChenPageof 11